G. Gouhier et al.
FULL PAPER
[
6-(2,3-Di-O-benzyl-1-ethylthio-β-
-methyl-1H-imidazol-3-ium Bromide 4: Compound 3 (2.1 g,
.61 mmol) and 1-methylimidazole (0.431 mL, 5.42 mmol,
.5 equiv.) in acetonitrile (20 mL) were stirred under argon at reflux
D
-glucopyranos-6-yl)-6-oxohexyl]-
imidazol-3-ium Hexafluorophosphate (10): Compound 5 (20 mg,
29.3 µmol) and 1 (14 mg, 19.5 µmol) in dried dichloromethane
(2 mL) were treated with TMSOTf (1.4 µL, 14.7 µmol) according
to Procedure A. Compound 10 (22 mg, 17.4 µmol, 89%) was ob-
1
3
1
2
0
temperature for 5 h. The mixture was concentrated under reduced
pressure, and the crude product was washed with Et O (3 ϫ
0 mL). The diethyl ether phase was removed by decanting to yield
tained as a yellow oil. [α]
D
= 13.4 (c = 1.00, CHCl
m/z = 1105 [M] . H NMR (300 MHz, CDCl ): δ = 8.50 (s, 1 H,
C-H), 7.40–7.12 (m, 32 H, Ar, Im), 5.23 (t, J = 3.6 Hz, 1 H, 1Ј-
H), 4.97 (d, J = 10.8 Hz, 2 H, CH -Ph), 4.85 (d, J = 9.9 Hz, 2 H,
CH -Ph), 4.82 (d, J = 11 Hz, 2 H, CH -Ph), 4.80 (d, J = 10.8 Hz,
2 H, CH -Ph), 4.79 (d, J = 12 Hz, 2 H, CH -Ph), 4.78 (d, J =
-Ph), 4.77 (d, J = 11 Hz, 1 H, CH- 11 Hz, 2 H, CH -Ph), 4.71 (d, J = 9.6 Hz, 1 H, 1-H), 4.33 (m, 2
H, 2ϫ6-H), 4.15 (m, 2 H, 4-H, 5-H), 4.05–4.01 (m, 1 H, 2Ј-H),
3.96 (t, J = 9.3 Hz, 1 H, 4Ј-H), 3.89 (s, 3 H, CH ), 3.73–3.41 (m, 7
H, 2-H, 3-H, 3Ј-H, 4Ј-H, 5Ј-H, 2ϫ6Ј-H), 2.79–2.71 (m, 2 H, CH
), 2.38 (t, J = 7.2 Hz, 2 H, S-CH -CH ), 1.88–1.79 (m, 2 H, CH
1.69–1.63 (m, 6 H, 3 CH ), 1.38–1.32 (m, 3 H, S-CH -CH
C NMR (75 MHz, CDCl ): δ = 173.1 (C=O), 139.3 (N C), 138.8–
136.3 (Ar), 128.5–127.4 (Ar), 123.5 (Ar), 122.2 (Im), 91.1 (C-1Ј),
85.9 (C-1), 84.4 (C-3), 81.6 (C-5), 81.1 (C-3Ј), 79.8 (CH -Ph), 77.7
Ar), 124.7 (Im), 123.3 (Im), 85.9 (C-1), 85.4 (C-3), 81.4 (C-5), 77.4 (CH -Ph), 77.6 (CH ), 75.6 (CH -Ph), 74.9 (CH -Ph), 74.6 (CH
CH ), 75.6 (CH -Ph), 75.5 (CH -Ph), 70.4 (C-4), 64.3 (C-2), 50.1 Ph), 73.3 (CH -Ph), 73.0 (C-4Ј), 70.4 (C-4), 70.0 (C-5Ј), 68.4 (C-
C-6), 37.0 (CH ), 34.5 (CH ), 30.4 (CH ), 26.1 (S-CH -CH ), 25.4 2Ј), 63.4 (C-2), 49.1 (C-6), 35.9, 33.4, 29.7, 25.0, 24.9, 24.3, 23.8,
CH ), 23.9 (CH ), 15.3 (S-CH -CH ) ppm.
6-(2,3-Di-O-benzyl-1-ethylthio-β- -glucopyranos-6-yl)-6-oxohexyl]-
-methyl-1H-imidazol-3-ium Hexafluorophosphate (1): Potassium
3
). MS (ESI):
+
1
2
3
3
4
1
N
2
2
0
(2.03 g, 3.07 mmol, 85%) as a viscous yellow oil. [α]
D
= 9.2 (c =
). MS (ESI): m/z = 583 [M] . H NMR (300 MHz,
): δ = 8.46 (s, 1 H, N C-H), 7.39–7.22 (m, 12 H, Ar, Im),
.93 (d, J = 9.9 Hz, 2 H, CH
2
+
1
.00, CHCl
3
2
2
CDCl
4
3
2
2
2
2
2
Ph), 4.73 (d, J = 11 Hz, 1 H, CH-Ph), 4.47 (d, J = 9.6 Hz, 1 H, 1-
H), 4.28 (m, 2 H, 6-H, 6Ј-H), 4.11 (m, 2 H, 5-H, 4-H), 3.85 (s, 3
H, CH
3
3
), 3.51–3.37 (m, 4 H, 2-H, 3-H), 2.78–2.71 (m, 2 H, CH
.34 (t, J = 7.2 Hz, 2 H, S-CH -CH ), 1.87–1.79 (m, 2 H, CH
.71–1.65 (m, 4 H, 2 CH ), 1.38–1.28 (m, 3 H, S-CH -CH
CN): δ = 174.2 (C=O), 140.7 (N C), 139.7
Ar), 137.5 (Ar), 129.4 (Ar), 129.3 (Ar), 129.3 (Ar), 129.2 (Ar),
29.1 (Ar), 129.0 (Ar), 128.8 (Ar), 128.7 (Ar), 128.5 (Ar), 128.4
2
),
2
),
),
2
1
2
3
2
2
3
2
2
2
3
) ppm.
2
2
3
) ppm.
1
3
13
C NMR (75 MHz, CD
3
2
3
2
(
1
(
(
(
(
2
2
3
2
2
2
-
3
2
2
2
2
2
2
2
3
1
9
1
2
2
2
3
14.7 ppm. F NMR (282.5 MHz, CDCl
10 Hz) ppm.
3 P,F
): δ = –73.8 (d, J =
7
[
1
D
General Procedure B. Glycosylation with Thioethyl Activation: Ac-
ceptor 16 or 17 (1.5 equiv.) in dichloromethane was added to a
solution of 10 in dichloromethane in the presence of molecular
sieves (4 Å) under argon at 0 °C. NBS (1.2 equiv.) and TMSOTf
hexafluorophosphate (0.625 g, 3.40 mmol, 1.1 equiv.) was stirred
with 4 (2 g, 3.09 mmol) in a mixture of acetonitrile and water (1:1,
2
reduced pressure, and the crude product was dissolved in dichloro-
methane, then washed with water and brine. The organic layer was
4
dried (MgSO ), filtered, and the solvent was evaporated to obtain
1
=
0 mL) at room temp. for 2 h. The solvents were removed under
(
0.75 equiv.) were added, and the mixture was stirred at room temp.
for 3 h. The reaction mixture was concentrated under reduced pres-
sure and washed three times with Et O. The solvents were removed
2
0
2
(2.25 g, 3.09 mmol, 100%) as a viscous yellow oil. [α]
D
= 11.3 (c
). MS (ESI): m/z = 583 [M] . H NMR (300 MHz,
): δ = 8.48 (s, 1 H, N C-H), 7.39–7.16 (m, 32 H, Ar, Im),
+
1
by decantation, and the obtained oil was dissolved in dichloro-
methane and washed with water and brine. The organic phase was
dried (MgSO ), filtered, and the solvent was evaporated under re-
4
duced pressure to obtain the desired trisaccharide as a viscous yel-
low oil.
1.00, CHCl
3
CDCl
3
2
5
.27 (t, J = 3.6 Hz, 1 H, 1Ј-H), 4.99 (d, J = 10.8 Hz, 2 H, CH
Ph), 4.91 (d, J = 9.9 Hz, 1 H, CH -Ph), 4.86 (d, J = 11 Hz, 1 H,
CH -Ph), 4.81 (d, J = 10.6 Hz, 2 H, CH -Ph), 4.80 (d, J = 11.4 Hz,
H, CH -Ph), 4.76 (d, J = 9.6 Hz, 1 H, 1-H), 4.75 (s, 1 H, CH
Ph), 4.71 (s, 1 H, CH -Ph), 4.61 (s, 1 H, CH -Ph), 4.31 (m, 2 H, 2
-H), 4.13 (m, 2 H, 4-H, 5-H), 4.11–4.03 (m, 1 H, 4Ј-H), 4.01 (t, J
9.7 Hz, 1 H, 2Ј-H), 3.87 (s, 3 H, CH ), 3.78–3.61 (m, 5 H), 3.53–
.36 (m, 4 H), 2.98 (d, J = 2.4 Hz, 1 H), 2.81–2.69 (m, 2 H), 2.36
t, J = 7.2 Hz, 2 H), 1.88–1.79 (m, 2 H), 1.72–1.63 (m, 4 H), 1.35–
2
-
2
2
2
1
2
2
-
{
6-[2,3,4,6-Tetra-O-benzyl-α-
benzyl-α- -glucopyranosyl-(1Ǟ4)-2,3,6-tri-O-benzyl-1-methoxy-α-
-glucopyranos-6 -yl]-6-oxohexyl}-1-methyl-1H-imidazol-3-ium
Hexafluorophosphate (18): Compound 10 (20 mg, 15.8 µmol) and
6 (5 mg, 10.1 µmol) in dried dichloromethane (2 mL) were treated
D-glucopyranosyl-(1Ǟ4)-2,3-di-O-
2
2
D
6
=
3
(
1
1
(
7
II
D
3
1
with TMSOTf (1.1 µL, 11.9 µmol) and NBS (3 mg, 19.0 µmol) ac-
cording to Procedure B. Compound 18 (22 mg, 13.4 µmol, 85%)
13
.31 (m, 3 H) ppm. C NMR (75 MHz, CDCl
3
): δ = 174.3 (C=O),
40.5–137.6 (Ar), 129.5–128.6 (Ar), 124.7 (Im), 123.4 (Im), 92.3
C-1Ј), 87.1 (C-1), 85.6 (C-3), 82.8 (C-5), 81.0 (C-3Ј), 78.9, 78.8,
6.8, 76.1, 75.8, 74.5, 74.2 (C-4Ј), 71.6 (C-4), 71.2 (C-5Ј), 69.6 (C-
), 50.3 (C-6), 37.1, 34.6, 30.5, 26.2, 25.5, 25.0, 15.9 ppm. F NMR
2
0
was obtained as a viscous yellow oil. [α]
D
= 45.7 (c = 1.00, CHCl
MS (ESI): m/z = 1508 [M] . H NMR (300 MHz, CDCl ): δ = 8.47
s, 1 H, N C-H), 7.38–7.10 (m, 47 H, Ar, Im), 5.45 (d, J = 3.8 Hz,
H, 1"-H), 5.21 (t, J = 3.6 Hz, 1 H, 1Ј-H), 4.94 (d, J = 10.8 Hz, 2
3
).
+
1
3
(
2
19
2
(
(
1
1
282.5 MHz, CDCl
3
): δ = –72.1 (d, JP,F = 710 Hz) ppm. HRMS
H, CH
2
-Ph), 4.91 (d, J = 9.9 Hz, 1 H), 4.83–4.81 (m, 3 H), 4.79 (d,
-Ph), 4.75–4.71 (m,
-Ph), 4.41–4.36 (m, 2 H, 2ϫ6-H), 4.31 (s, 2 H),
.17–4.03 (m, 2 H, 4Ј-H, 5-H), 4.04–3.90 (m, 3 H, 4ЈЈ-H, 2ЈЈ-H),
.90 (t, J = 9.1 Hz, 1 H, 2Ј-H), 3.86 (s, 3 H, CH ), 3.68–3.43 (m,
3 H), 3.3 (s, 3 H), 2.93 (d, J = 6.8 Hz, 1 H, CH ), 2.71–2.65 (m,
H, CH ), 2.35 (m, 2 H, CH ), 1.86–1.71 (m, 2 H, CH ), 1.66–
.63 (m, 4 H, 2 CH ) ppm. C NMR (75 MHz, CDCl ): δ = 173.5
+
43 2 6
ESI): calcd. for C32H N O S [M] 583.2842; found 583.2858.
J = 10.8 Hz, 1 H), 4.77 (d, J = 12 Hz, 2 H, CH
2
General Procedure A. Glycosylation with TCA Donors: Under ar-
gon, at 0 °C, TCA donor 5–9 (1.5 equiv.) in dichloromethane was
added to a solution of 1 in dichloromethane, in the presence of
molecular sieves (4 Å). TMSOTf (0.75 equiv.) was added, and the
solution was stirred at room temp. for 1.5 h. The reaction mixture
was concentrated under reduced pressure and washed three times
with Et
tained oil was dissolved in dichloromethane and washed with water
and brine. The organic phase was dried (MgSO ), filtered, and the
4
4
3
1
2
1
H, 1-H, CH
2
3
2
2
2
2
13
2
3
2
O. The solvent was removed by decanting, and the ob-
(
C=O), 139.7–136.8 (Ar), 128.9–127.8 (Ar), 123.9 (Im), 122.6 (Im),
9
8
1.8 (C-1ЈЈ), 91.5 (C-1Ј), 86.3 (C-1), 84.7 (C-3), 82.0, 81.5 (C-5),
0.2 (C-3Ј), 80.0, 78.1 (CH -Ph), 78.0 (CH -Ph), 77.5 (CH ), 76.0
-Ph), 75.3 (CH -Ph), 75.0 (CH -Ph), 73.9
-Ph), 73.4 (C-4Ј), 70.9, 70.8 (C-4), 70.7 (C-5Ј), 70.4 (C-2Ј),
4
2
2
3
solvent was evaporated under reduced pressure to obtain the de-
sired disaccharide as a viscous yellow oil.
(CH
CH
2
2
-Ph), 75.7 (CH
2
2
2
(
{
6-[4-O-(2,3,4,6-Tetra-O-benzyl-α-
D
-glucopyranosyl)-2,3-di-O-
63.8 (C-2), 62.9, 55.5, 49.5 (C-6), 36.3, 33.8, 25.4, 24.7, 24.2 ppm.
1
9
1
benzyl-1-ethylthio-β- -glucopyranos-6-yl]-6-oxohexyl}-1-methyl-1H-
D
F NMR (282.5 MHz, CDCl
3
): δ = –73.3 (d, JP,F = 710 Hz) ppm.
6370
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 6366–6371